Michael Burry Stock Portfolio: 6 Stocks to Buy

3. Bruker Corporation (NASDAQ:BRKR)

Scion Asset Management Equity Stake: $10.30 Million

Stock Performance (end Q2-October 9): -14.63%

Number of Hedge Fund Holders: 42

Bruker Corporation (NASDAQ:BRKR) is one of the top stocks in Michael Burry’s stock portfolio. On October 3, the company confirmed it had received new orders for advanced Nuclear Magnetic Resonance instrumentation. The $10 million order is from the New York Structural Biology Center (NYSBC), the University of Delaware, and Northwestern University.

The advanced Nuclear Magnetic resonance instrumentation is tailored to enable research institutes to pursue breakthroughs in drug discovery and disease biology disciplines. The system comes with a fast NMR sample shuttle system, a magnetic tunnel, and an electromagnetic field cycling coil FCC.

The NMR Relaxometry system enables measurements of spin-lattice relaxation rate constants for 1H, 15N, 13C, and other spins in biological macromolecules. It also comes with proteins and nucleic acids, over the range of magnetic fields from 100 µT to 16.4 T.

“Critically, this instrumentation opens new time regimes for elucidating dynamics of these molecules and enables research ranging from understanding fundamental biological processes in normal and pathological states to discovery of potential new drugs for treatment of cancer and other diseases,” said Arthur G. Palmer, Professor of Biochemistry and Molecular Biophysics at Columbia University and Director of NMR Spectroscopy at NYSBC.

Bruker Corporation (NASDAQ:BRKR) develops, manufactures, and distributes high-performance scientific instruments and analytical solutions used in life sciences, applied sciences, and industrial applications, enabling customers to explore life and materials at the microscopic, molecular, and cellular levels. Its products include nuclear magnetic resonance (NMR) spectrometers, mass spectrometry systems, atomic force microscopes, and preclinical imaging systems.